IFN-γ-driven UBE2D3 upregulation impairs antigen presentation pathways and anti-tumor immunity in pancreatic cancer
Open Access
- 28 November 2025
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 10733
Abstract
Although ubiquitin-conjugating enzymes are critical regulators of cellular function and fate, their roles in tumorigenesis remain incompletely defined. Here, we provide genetic and molecular evidence that the Ubiquitin-Conjugating Enzyme E2 D3 (UBE2D3) is specifically overexpressed in cancerous pancreatic ductal cells, including early-stage pancreatic intraepithelial neoplasia and advanced pancreatic ductal adenocarcinoma (PDAC). This overexpression is independent of oncogenic KRAS status and is driven by the inflammatory tumor microenvironment, particularly interferon-γ (IFN-γ). Mechanistically, UBE2D3 binds the ubiquitin ligase Kelch Like Family Member 13 (KLHL13) to mediate K63-linked polyubiquitination at lysine 245 of transporter 2 (TAP2), resulting in steric hindrance that blocks the transporter. Genetic or pharmacologic inhibition of UBE2D3 enhances antigen presentation in cancer cells and restores CD8+ T-cell-mediated tumor surveillance in pancreatic cancer models in male mice. Furthermore, combining an UBE2D3 small-molecule inhibitor with KRASG12D-specific TCR-T-cell therapy yields synergistic antitumor effects. Our findings reveal a negative feedback mechanism in which cancer cells, “camouflaging” themselves, evade IFN-γ-induced antigen presentation via UBE2D3 upregulation, highlighting a potential therapeutic target for enhancing antitumor immunity.Keywords
Funding Information
- National Natural Science Foundation of China (82572962)
This publication has 84 references indexed in Scilit:
- Complete but curtailed T-cell response to very low-affinity antigenNature, 2009
- Molecular Mechanisms of IFN-γ to Up-Regulate MHC Class I Antigen Processing and PresentationInternational Reviews of Immunology, 2009
- The Rap GTPases Regulate B Cell Morphology, Immune-Synapse Formation, and Signaling by Particulate B Cell Receptor LigandsImmunity, 2008
- Regulation of Interferon‐γ During Innate and Adaptive Immune Responses2007
- Molecular mechanisms of lymphocyte-mediated cytotoxicity.2005
- Immunoselective Pressure and Human Leukocyte Antigen Class I Antigen Machinery Defects in Microsatellite Unstable Colorectal CancersCancer Research, 2005
- Regulation of p53 by the Ubiquitin-conjugating Enzymes UbcH5B/C in VivoJournal of Biological Chemistry, 2004
- Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway.2001
- Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2Immunogenetics, 1993
- INDUCTION AND CHEMOTHERAPEUTIC RESPONSE OF 2 TRANSPLANTABLE DUCTAL ADENOCARCINOMAS OF THE PANCREAS IN C57BL-6 MICE1984